Kissei Pharmaceutical Co (TSE:4547) Tariff Resilience Score: 8/10 (As of Aug. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4547 Kissei Pharmaceutical Co Ltd TSE:4547
79 GF Score
Price 円3,860.00
GF Value 円4,688.48
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Kissei Pharmaceutical Co Tariff Resilience Score?

Kissei Pharmaceutical Co TSE:4547 +0.13% 79 Tariff Resilience Score is 8 as of Aug. 04, 2026. GuruFocus rates TSE:4547 with a GF Score™ of 79/100 and a GF Value™ of 円4,688.48 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 1,027 Drug Manufacturers companies, Kissei Pharmaceutical Co ranks better than 99.61% on this metric.

Kissei Pharmaceutical Co has the Tariff Resilience Score of 8, which implies that the company might have Highly Resilient.

Kissei Pharmaceutical Co has Kissei Pharmaceutical has limited exposure to tariffs due to its focus on domestic markets and minimal reliance on international supply chains. The pharmaceutical industry often benefits from tariff exemptions, reducing vulnerability.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Kissei Pharmaceutical Co might have Highly Resilient.

Kissei Pharmaceutical Co  (TSE:4547) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Kissei Pharmaceutical Co Tariff Resilience Score Related Terms

TSE:4547 vs ZTS: Tariff Resilience Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kissei Pharmaceutical Co's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kissei Pharmaceutical Co Tariff Resilience Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kissei Pharmaceutical Co's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Kissei Pharmaceutical Co's Tariff Resilience Score falls into.


TSE:4547
79GF Score
Kissei Pharmaceutical Co Ltd TSE:4547
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 8 mean?
Kissei Pharmaceutical Co (TSE:4547) has a Tariff Resilience Score of 8 as of Aug. 04, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Kissei Pharmaceutical Co ranks #4 out of 1027 companies in the Drug Manufacturers industry, placing it in the top 0.40000000000001%.
Is Kissei Pharmaceutical Co's Tariff Resilience Score too high?
Kissei Pharmaceutical Co's current Tariff Resilience Score is 8. Based on the distribution chart, Kissei Pharmaceutical Co ranks #4 out of 1027 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Kissei Pharmaceutical Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kissei Pharmaceutical Co's Tariff Resilience Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Kissei Pharmaceutical Co ranks #4 out of 1027 companies for Tariff Resilience Score. This places Kissei Pharmaceutical Co in the top 0% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Drug Manufacturers company?
A good Tariff Resilience Score depends on the Drug Manufacturers industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Kissei Pharmaceutical Co's current Tariff Resilience Score is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kissei Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Kissei Pharmaceutical Co (TSE:4547) is currently considered Modestly Undervalued. The stock's GF Value™ is 円4,688.48, compared to a current price of 円3,860.00 — trading 17.7% below its estimated fair value. The current Tariff Resilience Score is 8. Kissei Pharmaceutical Co's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Kissei Pharmaceutical Co (TSE:4547), the current Tariff Resilience Score is 8 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kissei Pharmaceutical Co (TSE:4547) Overvalued in 2026?

Based on GuruFocus' analysis, Kissei Pharmaceutical Co stock appears to be undervalued. The current stock price of 円3,860.00 is trading 17.7% below its estimated GF Value™ of 円4,688.48. GuruFocus considers Kissei Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for TSE:4547:

  • Tariff Resilience Score: 8
  • GF Value™: 円4,688.48 vs. price of 円3,860.00 (17.7% below fair value)
  • GF Score™: 79/100 with 1 warning sign

No single metric tells the full story. See the TSE:4547 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kissei Pharmaceutical Co Business Description

Address 19-48, Yoshino, Matsumoto City, Nagano, JPN, 399-8710
Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
79GF Score

Get the complete analysis for TSE:4547

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,860.00
Price
円4,688.48
GF Value